Details.
A minimally invasive mitral valve replacement option for high surgical risk patients with symptomatic deterioration after tissue mitral valve replacement. The procedure may use access through the groin blood vessels or the chest and avoids opening the chest wall, stopping the heart, and using bypass. Evaluation includes cardiac CT and echocardiography to determine suitability. Patients are monitored for one to two days afterward, including a comprehensive echocardiogram within 24 hours to assess valve function and check for complications.